Small declines in VAT, TAT, and SAT were observed over 24 weeks, although the loss of VAT did not reach statistical significance.
← all excerpts
A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial.
1
—
—